Want to join the conversation?
$ROP 2Q15 PR: “We were pleased with our performance in 2Q15. Our EBITDA margin increased 60BP to 33.9%. Revenue from acquisitions completed in last year contributed 4% growth, more than offsetting a 3% decline due to FX. Importantly, free cash flow was exceptional, as YTD free cash flow increased 24% to $412MMm” said Brian Jellison, President & CEO
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.